Work

Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol

Year: 2023

Type: article

Study design: Study Protocol

Source: Psychiatry Research

DOI: 10.1016/j.psychres.2023.115585

Authors: Brandon M. Kitay, Eva Murphy, Matthew Macaluso, Philip R. Corlett, Rachel Hershenberg, Jutta Joormann, Valeria Martinez-Kaigi, Sina Nikayin, Taeho Greg Rhee, Gerard Sanacora, Richard C. Shelton, Michael E. Thase, Samuel T. Wilkinson

Institutions: Emory University, Yale University, University of Alabama at Birmingham, University of Connecticut, University of Pennsylvania

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Institute of Mental Health, National Center for Advancing Translational Sciences

Awards: A feasibility trial of esketamine plus cognitive behavioral therapy for patients with major depressive disorder who are hospitalized for suicidal ideation, Yale Clinical and Translational Science Award

OpenAlex ID: W4388104285

FWCI: 1.556

Cites: 44

Cited by: 10

Related to: 10